Ae R. Jung

Seoul St. Mary's Hospital, Seoul 06591
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Novel Therapeutic Strategy for Renal Cell Carcinoma: Niclosamide Enhances Sunitinib Efficacy via DNA Repair and Cell Cycle Pathways.

Novel Therapeutic Strategy for Renal Cell Carcinoma: Niclosamide Enhances Sunitinib Efficacy via DNA Repair and Cell Cycle Pathways.

Journal: International journal of molecular sciences

Published: September 18, 2025

Integrated Bioinformatics Analysis Identified ASNS and DDIT3 as the Therapeutic Target in Castrate-Resistant Prostate Cancer.

Integrated Bioinformatics Analysis Identified ASNS and DDIT3 as the Therapeutic Target in Castrate-Resistant Prostate Cancer.

Journal: International journal of molecular sciences

Published: January 18, 2024

Erectile Dysfunction Treatment Using Stem Cell Delivery Patch in a Cavernous Nerve Injury Rat Model.

Erectile Dysfunction Treatment Using Stem Cell Delivery Patch in a Cavernous Nerve Injury Rat Model.

Journal: Bioengineering (Basel, Switzerland)

Published: April 27, 2023

Niclosamide exerts anticancer effects through inhibition of the FOXM1-mediated DNA damage response in prostate cancer.

Niclosamide exerts anticancer effects through inhibition of the FOXM1-mediated DNA damage response in prostate cancer.

Journal: American journal of cancer research

Published: January 26, 2021

HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancer.

HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancer.

Journal: American journal of cancer research

Published: November 29, 2020

Stem Cell/Oxygen-Releasing Microparticle Enhances Erectile Function in a Cavernous Nerve Injury Model.

Stem Cell/Oxygen-Releasing Microparticle Enhances Erectile Function in a Cavernous Nerve Injury Model.

Journal: Tissue engineering. Part A

Published: March 04, 2020

Direct differentiation of insulin-producing cells from human urine-derived stem cells.

Direct differentiation of insulin-producing cells from human urine-derived stem cells.

Journal: International journal of medical sciences

Published: April 24, 2019

Author Correction: Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer.

Author Correction: Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer.

Journal: Scientific reports

Published: April 17, 2019

GV1001 inhibits cell viability and induces apoptosis in castration-resistant prostate cancer cells through the AKT/NF-κB/VEGF pathway.

GV1001 inhibits cell viability and induces apoptosis in castration-resistant prostate cancer cells through the AKT/NF-κB/VEGF pathway.

Journal: Journal of Cancer

Published: March 13, 2019

Stem Cells Seeded on Multilayered Scaffolds Implanted into an Injured Bladder Rat Model Improves Bladder Function.

Stem Cells Seeded on Multilayered Scaffolds Implanted into an Injured Bladder Rat Model Improves Bladder Function.

Journal: Tissue engineering and regenerative medicine

Published: December 16, 2018

Therapeutic Effect of Controlled Release of Dual Growth Factor Using Heparin-Pluronic Hydrogel/Gelatin-Poly (Ethylene Glycol)-Tyramine Hydrogel System in a Rat Model of Cavernous Nerve Injury.

Therapeutic Effect of Controlled Release of Dual Growth Factor Using Heparin-Pluronic Hydrogel/Gelatin-Poly (Ethylene Glycol)-Tyramine Hydrogel System in a Rat Model of Cavernous Nerve Injury.

Journal: Tissue engineering. Part A

Published: August 29, 2018

High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer.

High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer.

Journal: Journal of Cancer

Published: June 25, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026